A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/517 (2006.01)
Patent
CA 2544863
This invention relates to a method of treatment of cancer with a combination of an erbB2 ligand and an antibody, in mammals. More particularly, this invention relates to a method of treating cancer by administering an erbB2 ligand in combination with an erbB antibody. This invention also relates to a kit useful in the treatment of abnormal cell growth in mammals, especially humans.
L'invention concerne une méthode de traitement du cancer chez les mammifères avec une association d'un ligand de erbB2 et d'un anticorps. Plus particulièrement, la présente invention concerne une méthode de traitement du cancer par l'administration d'un ligand de erbB2 en association avec un anticorps anti-erbB. Elle concerne également une trousse utile dans le traitement d'une croissance cellulaire anormale chez les mammifères, notamment chez l'homme.
Connell Richard Damian
Denis Louis Jean
Jani Jitesh Pranlal
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Selective erbb2 inhibitor/anti-erbb antibody combinations in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective erbb2 inhibitor/anti-erbb antibody combinations in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective erbb2 inhibitor/anti-erbb antibody combinations in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1555574